DAVID E ELLIOTT, MD PHD
Osteopathic Medicine at Hawkins Dr, Iowa City, IA
License number
Iowa 28232
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Iowa 28232
Category
Osteopathic Medicine
Type
Gastroenterology
License number
Iowa 28232
Category
Osteopathic Medicine
Type
Hepatology
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 356-3127
(319) 353-6399 (Fax)
(319) 353-6399 (Fax)
Organization information
See more information about DAVID E ELLIOTT at bizstanding.comUniversity Of Iowa Health Care - David E Elliott MD
200 Hawkins Dr #5401JCP, Iowa City, IA 52242
Categories:
Gastroenterology Physicians & Surgeons
Phone:
(319) 356-3127 (Phone)
Professional information
David Eric Elliott, Iowa City IA
Specialties:
Gastroenterologist
Address:
200 Hawkins Dr, Iowa City, IA 52242
Education:
Wayne State University, School of Medicine - Doctor of Medicine
Wayne State University - Doctor of Philosophy
Johns Hopkins Hospital - Residency - Internal Medicine
Wayne State University - Doctor of Philosophy
Johns Hopkins Hospital - Residency - Internal Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Gastroenterology (Internal Medicine)
Dr. David E Elliott, Iowa City IA - MD (Doctor of Medicine)
Specialties:
Gastroenterology
Address:
University Of Iowa Hospital-GAS
200 Hawkins Dr, Iowa City 52242
(319) 356-3127 (Phone)
200 Hawkins Dr, Iowa City 52242
(319) 356-3127 (Phone)
Certifications:
Gastroenterology, 2003, Internal Medicine, 2003
Awards:
Healthgrades Honor Roll
Languages:
English, French, Spanish
Hospitals:
University Of Iowa Hospital-GAS
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
Wayne State University School Of Medicine
Graduated: 1988
Johns Hopkins Hospital
Graduated: 1989
Graduated: 1991
University Iowa Hosps
Wayne State University School Of Medicine
Graduated: 1988
Johns Hopkins Hospital
Graduated: 1989
Graduated: 1991
University Iowa Hosps
Professor At University Of Iowa
Position:
Professor at University of Iowa
Location:
Iowa City, Iowa Area
Industry:
Hospital & Health Care
Work:
University of Iowa
-
Professor
Professor At University Of Iowa
Position:
Professor at University of Iowa
Location:
Iowa City, Iowa Area
Industry:
Higher Education
Work:
University of Iowa
-
Professor
David Eric Elliott, Iowa City IA
Specialties:
Internal Medicine, Gastroenterology, Hepatology
Work:
University Of Iowa Hospital & Clinic
200 Hawkins Dr, Iowa City, IA 52243
200 Hawkins Dr, Iowa City, IA 52243
Education:
Wayne State University (1988)
Use Of Parasitic Biological Agents For Prevention And Control Of Autoimmune Diseases
US Patent:
6764838, Jul 20, 2004
Filed:
Dec 11, 1998
Appl. No.:
09/209732
Inventors:
Joel V. Weinstock - Iowa City IA
David E. Elliott - Iowa City IA
David E. Elliott - Iowa City IA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
C12P 2104
US Classification:
435 711, 435325, 4241841, 4242651, 424520, 530350, 530412, 530855
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohns disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.
Use Of Parasitic Biological Agents For Diseases Prevention And Control
US Patent:
2010030, Dec 2, 2010
Filed:
Sep 19, 2008
Appl. No.:
12/234332
Inventors:
Joel V. Weinstock - Iowa City IA, US
David E. Elliott - Iowa City IA, US
David E. Elliott - Iowa City IA, US
Assignee:
University of Iowa, The Research Foundation - Iowa City IA
International Classification:
A61K 49/00, A61K 39/00, A61P 37/00, A61P 37/04, A61P 29/00, A61K 35/56, C12Q 1/02
US Classification:
424 91, 4242651, 424520, 435 29
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis, multiple sclerosis, autoimmune thyroiditis, allergic rhinitis, colon polyps/colon cancer and asthma can be treated by the methods and compositions disclosed therein.
Use Of Parasitic Biological Agents For Prevention And Control Of Autoimmune Diseases
US Patent:
7833537, Nov 16, 2010
Filed:
Jul 30, 2007
Appl. No.:
11/888061
Inventors:
Joel V. Weinstock - Iowa City IA, US
David E. Elliott - Iowa City IA, US
David E. Elliott - Iowa City IA, US
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
A61K 39/00, A61K 39/38, A61K 39/002, A01N 63/00, A01N 65/00
US Classification:
4242651, 4242691, 4241841, 424 931
Abstract:
The invention relates to a method of treating an excessive immune response including an aberrant/enhanced Th1 response by administering a helminthic parasite preparation in an amount sufficient to reduce the excessive immune response in an individual. This invention is generally directed to autoimmune diseases which involve an excessive immune response or an aberrant/enhanced Th1 response. More specifically, the present invention is directed to the treatment of Crohn's disease and ulcerative colitis, both known as IBD. While the present invention discloses specific information about the treatment of IBD, the disclosure is in no way limiting. Additionally, rheumatoid arthritis, type 1 diabetes mellitus, lupus erythematosis, sarcoidosis and multiple sclerosis can be treated by the methods and compositions disclosed therein.
Use Of Parasitic Biological Agents For Diseases Prevention And Control
US Patent:
2005011, Jun 2, 2005
Filed:
Nov 17, 2003
Appl. No.:
10/715659
Inventors:
Joel Weinstock - Iowa City IA, US
David Elliott - Iowa City IA, US
David Elliott - Iowa City IA, US
International Classification:
A61K039/05, G01N033/53, G01N033/569
US Classification:
435007220, 424245100
Abstract:
The invention relates to a method of screening a heminthic parasite preparation that affects a regulatory T cell function and a method of treating a disease by altering a regulatory T cell activity through the administration of a parasite preparation.